All stock lists
Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
Healthcare · Biotechnology
9.54-0.27 (-2.70%)
Insider Score
––Not scored
ZVRA Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ZVRA analyst forecast
ZVRA analyst consensus
Moderate Buy5 ratings
Buy 5 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ZVRA 12-month price target
No published price targets in the last 12 months.
Best analysts covering ZVRA
- Cantor Fitzgerald100%success rate · 3 calls
- Guggenheim100%success rate · 1 call
- Maxim Group100%success rate · 1 call
- Canaccord Genuity80%success rate · 5 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ZVRA analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-20 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-08-07 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-08-06 |
| — | BTIG | Buy | — | — | Reiterated | 2026-07-27 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-07-27 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-07-27 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-06-23 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-06-11 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-06-10 |
| — | Maxim Group | Buy | — | — | Reiterated | 2026-06-10 |
| — | Citizens | Market Outperform | — | — | Reiterated | 2026-06-09 |
| — | BTIG | Buy | — | — | Reiterated | 2026-06-09 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-06-09 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2026-06-08 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-05-08 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-11-06 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-11-06 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2025-08-13 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-07-10 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-05-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-13 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-03-13 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-03-13 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-03-12 |
| — | Citizens Capital Markets | Market Outperform | — | — | Reiterated | 2025-03-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-20 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-11-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-09-30 |
| — | Roth MKM | Buy | — | — | Reiterated | 2024-09-24 |
| — | Maxim Group | Buy | — | — | Reiterated | 2024-09-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-09-20 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-09-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-07-09 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-04-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-12-28 |
| — | Roth MKM | Buy | — | — | Reiterated | 2023-10-06 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-09-01 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-08-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-08-16 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2022-01-30 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2021-04-08 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2021-03-03 |
ZVRA earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-09 | 0.05 | 0.21 | $28.1M | $34.1M |
| 2026-05-06 | 0.06 | 0.60 | $32.0M | $36.2M |
| 2026-08-05 | 0.11 | 0.14 | $33.9M | $39.7M |
| 2026-11-03 | 0.14 | 0.00 | $37.1M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.